NPI: 1881987485 · PARKLAND, WA 98444 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/16/2011
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 05/16/2011 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 29,797 | $603K |
| 2019 | 26,866 | $667K |
| 2020 | 28,966 | $715K |
| 2021 | 20,654 | $536K |
| 2022 | 21,528 | $583K |
| 2023 | 9,040 | $666K |
| 2024 | 3,948 | $564K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 51,590 | 3,662 | $4.14M |
| A4657 | Syringe, with or without needle, each | 4,039 | 2,154 | $91K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 43,375 | 2,118 | $57K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 698 | 352 | $33K |
| J1756 | Injection, iron sucrose, 1 mg | 10,040 | 2,154 | $10K |
| J1270 | Injection, doxercalciferol, 1 mcg | 20,189 | 1,417 | $1K |
| 90674 | 91 | 70 | $253.36 | |
| G0008 | Administration of influenza virus vaccine | 115 | 97 | $85.51 |
| 0012A | 19 | 15 | $80.00 | |
| 0011A | 20 | 17 | $16.94 | |
| 85048 | 2,083 | 1,446 | $0.00 | |
| 85041 | 2,096 | 1,452 | $0.00 | |
| 83970 | 1,403 | 972 | $0.00 | |
| 83540 | 1,035 | 687 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 317 | 49 | $0.00 |
| 83550 | 974 | 646 | $0.00 | |
| 82728 | 997 | 669 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,103 | 577 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 602 | 421 | $0.00 |
| 87340 | 13 | 12 | $0.00 |